Form 8-K Edwards Lifesciences For: Dec 06
FREE Breaking News Alerts from StreetInsider.com!
- Tech selloff weighs down Wall Street as bond yields climb
- Baidu slips as Q2 results miss estimates despite growth in AI cloud business
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
- Home Depot beats estimates, reaffirms fiscal 2026 guidance
- Citi says positioning risk is shifting from short squeezes to profit-taking
- Wall Street indexes slip as oil prices rise, retail results awaited
- Micron rises as White House presses Apple to avoid Chinese memory chips
- Tech selloff weighs down Wall Street as bond yields climb
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- Francisco Partners to acquire Weave Communications for $650M
Edwards Lifesciences (EW) PT Lowered to $85 at Truist Securities
December 9, 2022 7:32 AM ESTTruist Securities analyst Richard Newitter lowered the price target on Edwards Lifesciences (NYSE: EW) to $85.00 (from $95.00) while maintaining a Buy rating.
The analyst commented, "While a planned CEO transition does add a new factor, EW's NYC I-Day is unlikely to sway the... More
